THE MDMA SHOP DIARIES

So MAPS embarked on a many years-lengthy effort to show which the drug had benefit for a medication, boosting $140 million from donors to purchase scientific trials. The Corporation shaped what's now Lykos a decade back to be a public-benefit corporation, in anticipation that MDMA-assisted therapy would get FDA acceptance and start to reap taxable